The frequencies of PPARG c.1347 CC, CT and TT genotypes were 57.01%, 38.00% and 4.99% in 521 NSCLC patients and 61.32%, 34.50%, and 4.18% in 1,030 non-cancer controls, respectively. This evidence concerns the gene PPARG and cancer.